The Five Critical Factors That Influence Investor Valuations On DSO Platforms
Why do some DSO platforms hit 20%+ EBIT margins while others stall at 10%?
At the HBI 2026 Oral Health Community Summit, held in partnership with Straumann Group, Dieter Meyer, Senior Partner at Bain & Company, broke down exactly what separates top-performing Dental Service Organisations in Europe.
Here are the 5 factors investors are considering when valuating DSO platforms:
1️⃣ Geographic Concentration, not just geographic spread
Leading platforms hold strong, defensible positions in a focused set of markets. Spreading yourself thinly across many regions without scale in any of them is a structural weakness.
2️⃣ Organic growth at the clinic level
Investors used to reward how fast you could grow inorganically. Today the real signal is consistent, clinic-by-clinic organic performance.
3️⃣ Systematic EBITDA improvement
Can you prove you're driving margin gains? Not just at the platform level, but clinic by clinic?
4️⃣ Genuine platform value
Many DSOs are still a collection of clinics wearing a platform label. The winners can clearly demonstrate value created above and beyond the sum of their parts.
5️⃣ A track record of value-accretive M&A
Investors track EBITDA performance of every clinic added, year over year. Can you show that the majority of your acquisitions improved?
